Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03923322

Botanical Tincture for Symptoms of Irritable Bowel Syndrome

Irritable Bowel Syndrome Characterized by Constipation Clinical Trial

Official title:
Randomized Pilot Trial of Botanical Tincture for Symptoms of Irritable Bowel Syndrome Constipation Predominant (IBS-C) Diagnosed on ROME IV Criteria

Clinical Trial Summary

The main purpose of this study is to investigate the feasibility of a follow-up larger RCT on the efficacy of Botanical Tincture to relieve abdominal pain in people with Irritable Bowel Syndrome Constipation Predominant (IBS-C).

Clinical Trial Description

The randomized pilot trial will address subject recruitment, retention, and subject compliance with protocol. A secondary is to learn if people with IBS-C are able to tolerate Botanical Tincture and the effect of taking Botanical Tincture on abdominal pain, bloating, and bowel movements. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03923322
Study type Interventional
Source Stamford Hospital
Contact Marc Brodsky, MD
Phone 203-276-4777
Email mbrodsky@stamhealth.org
Status Not yet recruiting
Phase Phase 2
Start date December 2023
Completion date January 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT01622972 - Mode of Action of Moviprep Phase 4
Recruiting NCT03687814 - Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation N/A
Completed NCT01722318 - The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Phase 2
Recruiting NCT04214470 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Completed NCT02493452 - Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) Phase 3
Completed NCT03573908 - A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Phase 3
Completed NCT00948818 - Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation Phase 3
Recruiting NCT03226145 - Reclassifying Constipation Using Imaging and Manometry N/A
Completed NCT02732743 - Food Supplement Physiomanna® Baby in Pediatric Patients N/A
Terminated NCT02837783 - A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) Phase 4
Completed NCT02387359 - The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Phase 3